As of 2026-10-04, the Relative Valuation of Arcus Biosciences Inc (RCUS) is (99.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.44 USD, the upside of Arcus Biosciences Inc based on Relative Valuation is -507.1%.
The range of the Relative Valuation is (91.44) - (106.43) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.9x - 29.1x | 27.0x |
| Forward P/E multiples | 25.0x - 29.8x | 27.4x |
| Fair Price | (91.44) - (106.43) | (99.48) |
| Upside | -474.1% - -535.5% | -507.1% |
| Date | P/E |
| 2026-10-02 | -6.68 |
| 2026-10-01 | -6.90 |
| 2026-09-30 | -7.06 |
| 2026-09-29 | -7.01 |
| 2026-09-28 | -6.84 |
| 2026-09-25 | -6.83 |
| 2026-09-24 | -6.85 |
| 2026-09-23 | -7.22 |
| 2026-09-22 | -7.35 |
| 2026-09-21 | -7.10 |
| 2026-09-18 | -6.90 |
| 2026-09-17 | -6.98 |
| 2026-09-16 | -6.74 |
| 2026-09-15 | -6.65 |
| 2026-09-14 | -6.58 |
| 2026-09-11 | -6.72 |
| 2026-09-10 | -7.15 |
| 2026-09-09 | -7.79 |
| 2026-09-08 | -7.95 |
| 2026-09-04 | -8.11 |
| 2026-09-03 | -8.24 |
| 2026-09-02 | -8.16 |
| 2026-09-01 | -8.12 |
| 2026-08-31 | -8.01 |
| 2026-08-28 | -7.99 |
| 2026-08-27 | -8.36 |
| 2026-08-26 | -8.41 |
| 2026-08-25 | -8.63 |
| 2026-08-24 | -8.24 |
| 2026-08-21 | -8.30 |
| 2026-08-20 | -8.07 |
| 2026-08-19 | -8.30 |
| 2026-08-18 | -8.07 |
| 2026-08-17 | -8.08 |
| 2026-08-14 | -8.06 |
| 2026-08-13 | -7.89 |
| 2026-08-12 | -7.92 |
| 2026-08-11 | -7.86 |
| 2026-08-10 | -7.85 |
| 2026-08-07 | -7.83 |
| 2026-08-06 | -7.75 |
| 2026-08-05 | -7.57 |
| 2026-08-04 | -7.87 |
| 2026-08-03 | -7.55 |
| 2026-07-31 | -7.71 |
| 2026-07-30 | -7.72 |
| 2026-07-29 | -7.23 |
| 2026-07-28 | -7.40 |
| 2026-07-27 | -7.61 |
| 2026-07-24 | -7.77 |